Navigation Links
Swedish Biotech Licenses HIV Drug to China for Development

The Swedish biotechnology company Medivir announced yesterday that it has licensed its experimental non-nucleoside// reverse transcriptase inhibitor (NNRTI), code-named MIV-160, to the Chinese company Guangdong Lantai Viewland Pharmaceutical for the China region. Medivir will retain the worldwide rights to the product.

Guangdong Lantai Viewland Pharmaceutical will potentially develop MIV-160 for three different products; an oral treatment regime, a vaginal microbicide and coating of condoms. It is the first antiretroviral product to be investigated as an additive agent to condom lubrication.

Professor Bo Oberg, head of the HIV franchise at Medivir, told aidsmap: 'This should enhance the safety of condoms and will at least save a few infections.'

MIV-160 is also an attractive microbicide product, he said, because it can inhibit HIV at very low concentrations – several thousand times lower than products currently being investigated in phase III trials in Africa. A second Medivir NNRTI – MIV-150 – is being investigated in combination with the microbicide Carraguard in a phase I study.

Medivir says that MIV-160, still in pre-clinical development, has shown good activity against NNRTI-resistant virus.

It is the first time that a Chinese company has won the global rights to develop an HIV product. Prof. Oberg said that Medivir will retain the right to commercialise or license any developments that result from the partnership for the rest of the world.

Medivir is also involved in two other development partnerships, with Tibotec for an HIV protease inhibitor and a nucleoside analogue, and with Bristol Myers Squibb for the NNRTI MIV-170.

Source-Bio-Bio Technology
SM
'"/>




Page: 1

Related medicine news :

1. Sick Swedish seagull was drunk, not affected by bird flu
2. GE Healthcare to Acquire Swedish Medical Company
3. Biotechnology industry expected to grow into a three billion dollar industry by 2002
4. Biotechnology on the lead
5. Panacea Biotech To Market Anthrax Vaccine
6. Commercialization of Biotech Discoveries, An Encouragement For Researchers
7. Biotech drug causing anemia-EPREX
8. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
9. Biologicals Transfer Proposal between US and Indian Biotechnology
10. Vical Biotech and NIH jointly develops HIV vaccine
11. Biotechnology Initiatives Planned In Hyderabad
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: